Вы находитесь на странице: 1из 14

Journal of Critical Care 43 (2018) 169–182

Contents lists available at ScienceDirect

Journal of Critical Care

journal homepage: www.jccjournal.org

Clinical management of pressure control ventilation: An algorithmic


method of patient ventilatory management to address “forgotten but
important variables”☆
Lonny Ashworth, MEd RRT FAARC a,⁎, Yasuhiro Norisue, MD b, Megan Koster, EdD RRT a, Jeff Anderson, MA RRT a,
Junko Takada, PT RRT b, Hatsuyo Ebisu, RN RRT b
a
Boise State University, Department of Respiratory Care, 1910 University Drive, Boise, ID, USA
b
Department of Pulmonary and Critical Care Medicine, Tokyo Bay Urayasu Ichikawa Medical Center, 3-4-32 Todaijima, Urayasu City, Chiba 2790001, Japan

a r t i c l e i n f o a b s t r a c t

Available online xxxx Pressure controlled ventilation is a common mode of ventilation used to manage both adult and pediatric popu-
Keywords: lations. However, there is very little evidence that distinguishes the efficacy of pressure controlled ventilation
Pressure control ventilation over that of volume controlled ventilation in the adult population. This gap in the literature may be due to the
Ventilation modes absence of a consistent and systematic algorithm for managing pressure controlled ventilation. This article pro-
Ventilator management algorithm vides a brief overview of the applications of both pressure controlled ventilation and volume controlled ventila-
Volume control ventilation tion and proposes an algorithmic approach to the management of patients receiving pressure controlled
Ventilator graphics ventilation. This algorithmic approach highlights the need for clinicians to have a comprehensive conceptual un-
Advanced mechanical ventilation derstanding of mechanical ventilation, pulmonary physiology, and interpretation of ventilator graphics in order
to best care for patients receiving pressure controlled ventilation. The objective of identifying a systematic ap-
proach to managing pressure controlled ventilation is to provide a more generalizable and equitable approach
to management of the ICU patient. Ideally, a consistent approach to managing pressure controlled ventilation
in the adult population will glean more reliable information regarding actual patient outcomes, as well as the ef-
ficacy of pressure controlled ventilation when compared to volume controlled ventilation.
© 2017 Elsevier Inc. All rights reserved.

1. Introduction The ability of the clinician to use PC-CMV to best treat a patient with
variable and often poor pulmonary mechanics depends upon an in-
Pressure control as a mode of ventilation was developed in the depth understanding of the mode and how to safely apply it to the spe-
1980's as an option to treat Acute Respiratory Distress Syndrome cific patient management scenario. Although nearly all ventilator man-
(ARDS) [1]. Pressure Control Ventilation (PCV), typically available as ufacturers now include one, if not several, options for PC-CMV or PC-
Pressure control–continuous mandatory ventilation (PC-CMV) or Pres- IMV, relatively little information is available to clinicians on how best
sure control-intermittent mandatory ventilation (PC-IMV), was de- to utilize the functions within these modes in a way that is most advan-
signed to deliver mechanical breaths at a set inspiratory tageous for their patients.
pressure—allowing clinicians to control the amount of distending pres- In reviewing the existing literature on the topic of algorithmic pa-
sure applied to airways and subsequently, to the alveoli. Because the tient management—specifically, literature explicit to PCV, it is important
amount of driving pressure applied to the airway is preset, the delivered to note that there was no consistency in how authors address or ap-
volume is variable and dependent upon the patient's inspiratory effort, proach methods of PCV management between and among studies.
pulmonary mechanics (i.e. pulmonary compliance, airway resistance This inconsistency may highlight a true lack of consensus among lead-
and AutoPEEP) and to a lesser extent, other ventilator settings, including ing physicians and respiratory therapists on how best to utilize pressure
rise time and inspiratory time. control ventilation. This article does not attempt to dictate a manage-
ment approach; rather, the goal of this article is to first provide a brief
overview of how PC-CMV differs from modes of volume ventilation,
then to highlight the detailed nature of the relationships between pul-
☆ Funding sources: none. Conflicts of interest: none.
⁎ Corresponding author at: Boise State University, Department of Respiratory Care,
monary mechanics and PC-CMV settings and finally, to suggest a
1910 University Drive, MS 1850, Boise, ID, USA. broad, yet systematic, algorithmic approach to managing patients in
E-mail address: lashwor@boisestate.edu (L. Ashworth). the Intensive Care Unit who are ventilated using PC-CMV.

http://dx.doi.org/10.1016/j.jcrc.2017.08.046
0883-9441/© 2017 Elsevier Inc. All rights reserved.
170 L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182

2. Pressure and volume controlled modes of ventilation consistently applied algorithm across studies that investigate the use
of PC-CMV may account for some of the variability in identifying the
Pressure-controlled ventilation (PCV) is a pressure-targeted, time- key differences between outcomes of patients ventilated using either
cycled mode of ventilation. During inspiration, the ventilator adjusts VC-CMV or PC-CMV. For example, when using VC-CMV in a patient
the flowrate to keep the airway pressure at the set level. The clinician who has a respiratory acidosis, the options for ventilator changes to en-
sets the peak inspiratory pressure (PIP), respiratory rate (f), inspiratory hance CO2 removal generally include increasing the tidal volume, in-
time (TI), positive end expiratory pressure (PEEP) and fraction of in- creasing the respiratory rate, or both. When ventilating a similar
spired oxygen (FIO2). The clinician also sets how quickly the PIP will patient with PC-CMV, although the options for enhancing CO2 removal
be reached with a control usually named slope, rise time or ramp, de- are mainly considered to be increasing the inspiratory pressure and f,
pending upon the brand of the ventilator. The most common mode of these options may have little effect and could be harmful due to in-
PCV is pressure-targeted assist-control (PC-CMV), in which a minimum creased asynchrony under certain conditions. There are a number of ad-
respiratory rate is set, but the patient is allowed to trigger additional justments that should be considered even before changing the two easy
breaths. Each breath, whether it is delivered at the set respiratory rate and attractive variables to help with CO2 removal if clinicians fully un-
or an additional breath triggered by the patient, is delivered at the set derstand the lung mechanics and ventilator graphics, which may poten-
PIP and the set TI. tially reduce patient ventilator asynchrony, ventilator days, and
Volume-controlled ventilation (VCV) is a volume-targeted mode in hopefully even mortality. The algorithm we suggest in this article pro-
which the tidal volume, respiratory rate (f), PEEP, inspiratory flowrate, vides clinicians with a systematic approach to adjust PC-CMV settings.
flow waveform, inspiratory pause time and inspiratory time are con-
trolled. The most common mode of VCV is volume-targeted assist-con- 5. Prerequisite physiological knowledge regarding inspiratory time,
trol (VC-CMV), in which a minimum f is set, but the patient is allowed to expiratory time and inspiratory pressure before using PC-CMV
trigger additional breaths. Each breath, regardless of whether it is pa-
tient or machine-triggered, will be delivered at the set tidal volume; 5.1. Time constant and autoPEEP
however, the airway pressure may vary as the patient's airway resis-
tance (Raw), compliance (C) and effort change. The time constant (TC) is a mathematical relationship between the
airway resistance and static compliance, and is related to the time it
3. Patient-ventilator synchrony during VC-CMV and PC-CMV takes to get gas into and out of the lung.

Although VC-CMV guarantees tidal volume, which appears to be an 


ideal mode for “lung protective strategy”, many clinicians prefer PC- Inspiratory Raw ¼ PIP−Pplat =Flowrateðl= secÞ
CMV to VC-CMV. The main reason for the preference is probably the su-
periority in patient-ventilator synchrony and thus patient comfort dur-
ing PC-CMV. To meet the respiratory demands of a patient, the 
ventilator's flow and pressure delivery must synchronize with the Cst ¼ VTE = Pplat −PEEP
patient's respiratory demands. The fact that a patient is able to control
inspiratory flowrate is the most important aspect of PC-CMV in terms
of patient-ventilator synchrony.
During PC-CMV, as the patient's airway resistance, compliance or ef- Cdyn ¼ VTE =ðPIP−PEEPÞ
fort changes, the inspiratory flowrate and tidal volume (VT) will poten-
tially change. To have a constant airway pressure during PC-CMV, the
ventilator varies the inspiratory flow based upon the inspiratory
flowrate of the patient. In other words, the spontaneously breathing pa- TC ¼ ðRawÞðCst Þ
tient is able to vary the inspiratory flowrate, and thus the tidal volume
as well, depending on his/her inspiratory effort, in contrast to VC-CMV Where: Raw = airway resistance (cm H2O/l/s); Cst = static compli-
where the inspiratory flow is set by the clinician [2]. When the patient's ance (l/cm H2O); Cdyn = dynamic compliance (l/cm H2O); VTE = ex-
flow demand is not met in VC-CMV, it is common that the demand for haled tidal volume (l); Pplat = plateau pressure, equivalent to average
tidal volume is not met. As a result, flow asynchrony is frequently ac- alveolar pressure at end inspiration (cm H2O); PIP = peak inspiratory
companied by cycle asynchrony and double triggering. pressure (cm H2O); TC = time constant (seconds).
The following two examples demonstrate a difference in the time
4. Comparing VC-CMV to PC-CMV in the literature constant for two patients. In a patient with COPD who is intubated
and mechanically ventilated, the airway resistance may be 25 cm H2O/
Studies have been published since the early 1990's comparing VC- l/s and the compliance may be 0.04 l/cm H2O. The expiratory resistance
CMV and PC-CMV. An article by Rittayami et al., published in 2015, will be higher than the inspiratory resistance in these patients, which
was a comprehensive review of published studies comparing VC-CMV results in a longer expiratory time constant [5]. In this case the inspira-
to PC-CMV. According to Rittayami, there were no differences in physi- tory time constant would be 1.0 s (25 cm H2O/l/s × 0.04 l/cm H2O). In a
ologic or clinical outcomes between the two modes and that adjusting patient with ARDS who is intubated and mechanically ventilated, the
the ventilator settings based upon the patient's individual characteris- airway resistance may be 12 cm H2O/l/s and the compliance may be
tics may help to reduce lung damage, minimize work of breathing, 0.02 l/cm H2O. In this case the time constant would be 0.24 s (12 cm
and improve patient comfort [3]. Findings from a 2015 Cochrane Review H2O/l/s × 0.02 l/cm H2O).
by Chacko, et al., stated that there was insufficient evidence that PC- The inspiratory time constant refers to the amount of inspiratory
CMV improved outcomes for people with acute lung injury when com- time required for the alveolar pressure to reach the set pressure during
pared to VC-CMV. The authors suggested that not only more, but larger PC-CMV. The inspiratory time must be equal to at least three and as long
studies may provide evidence as to whether PC-CMV improves out- as five time constants for the alveolar pressure to approximate the set
comes when compared to VC-CMV [4]. inspiratory pressure [5,6,7]. If the airway resistance or compliance in-
In reviewing the existing literature on the topic, it is important to creases, the inspiratory time constant will increase, and more time
note that there was no consistency in how a PC-CMV algorithm was ap- will be required for the alveolar pressure to reach the set pressure. If air-
plied to ventilator management between studies. The lack of a way resistance or pulmonary compliance decreases, the inspiratory
L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182 171

time constant will decrease and it will take less time for the alveolar The average alveolar pressure is estimated as the plateau pressure
pressure to reach the set pressure. (Pplat) during a 0.5–2.0 s inspiratory hold. It is recommended to monitor
The expiratory time constant influences the amount of expiratory and keep the Pplat b 25–30 cm H2O in all ventilated patients in traditional
time required for the patient to passively exhale to the PEEP level and “lung protective strategy”. In addition to monitoring the absolute num-
prevent AutoPEEP. The expiratory time must be equal to at least three ber of Pplat, increasing evidence is being published emphasizing the
to five expiratory time constants for the patient to exhale and minimize importance of targeting a Pplat – PEEP (ΔP) of b16 cm H2O, especially
or prevent AutoPEEP [6,7]. If the airway resistance or compliance in- in patients with severe ARDS. It has been shown that if the ΔP is
creases, the expiratory time constant will increase, and more time will N16 cm H2O in patients with severe ARDS, the relative risk of death in-
be required for complete exhalation and to prevent AutoPEEP. If airway creases [8]. Thus, permitting a low tidal volume, even b6 ml/kg, to keep
resistance or pulmonary compliance decreases, the expiratory time con- ΔP b16 cm H2O as long as pH is acceptable, seems a reasonable practice.
stant will decrease and it will take less time for complete exhalation to When a patient has an increased inspiratory effort, the pleural pres-
prevent AutoPEEP. sure (Ppl) becomes more negative. Clinically, we can estimate the pleu-
ral pressure by monitoring the esophageal pressure (Pes). This requires
the insertion of an esophageal balloon into the distal third of the thorac-
6. Inspiratory pressure on PC-CMV ic esophagus. After calibrating the system and ensuring that the balloon
is properly positioned, the pleural pressure is estimated by the esopha-
During PC-CMV, the manner in which the clinician sets the inspira- geal pressure.
tory pressure (PI) varies depending upon the specific ventilator used. A value that is sometimes used clinically is referred to as the
When using some ventilators, such as the Servo i or Servo U (Maquet), transpulmonary pressure (PL). The transpulmonary pressure is the av-
Puritan Bennett (PB) 840 or 980, and CareFusion's Avea, PI is set directly. erage alveolar pressure minus the pleural pressure (Ppl), and is reflec-
In other words, changes in PEEP will affect the total pressure but not the tive of the amount of strain on the lung. Care should be taken to not
distending pressure. In these cases, the PIP = PI + PEEP. In other venti- allow the patient in PC-CMV to breathe with a strong inspiratory effort
lators such as the Drager Evita XL and Drager V500 ventilators, PI is set as the transpulmonary pressure will increase.
as the difference between PIP and PEEP. In other words, PIP is set direct-
ly and the inspiratory pressure setting is referenced to atmospheric
pressure not PEEP. This is an important distinction - increases in PEEP
will now decrease the distending pressure and vice versa. PL ¼ Pplat −Ppl

Fig. 1. Normal waveforms in PC-CMV. Fig. 1 displays normal waveforms during PC-CMV. The top waveform demonstrates pressure (Paw) versus time, the middle waveform form
demonstrates flow versus time and the bottom waveform is volume versus time.
172 L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182

Fig. 2. Decreasing DeltaPInsp during inspiration. Fig. 2 demonstrates that the set airway pressure remains constant throughout inspiration, but as the alveolar pressure increases, the
DeltaPInsp (ΔP) decreases.

Fig. 3. Short inspiratory time. Fig. 3 demonstrates that if inspiratory time is too short, not allowing alveolar pressure to reach set airway pressure, inspiratory time ends before inspiratory
flowrate returns to baseline (as indicated by the red arrow) and tidal volume is reduced. (For interpretation of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182 173

During PC-CMV without spontaneous breathing, if Pplat – PEEP (ΔP) 8. Understanding the basic ventilator graphics to guide decisions
remains constant, as compliance decreases, exhaled tidal volume will
decrease. Similarly, as compliance increases, exhaled tidal volume will An understanding of the use of graphic analysis during mechanical
increase. ventilation is a key in managing patients receiving ventilatory support.
The importance of evaluating the pressure-versus-time and the flow-
 versus-time waveforms will be discussed in depth below.
Cst ¼ VTE = Pplat −PEEP
8.1. Pressure versus time waveform

7. Initial ventilator settings when beginning PC-CMV Fig. 1 is an example of a typical waveform of a patient ventilated in
PC-CMV. In this example, PIP 24 cm H2O, TI 0.9 s, f 20/min, PEEP
When initiating PC-CMV, although the settings below are frequently 6.0 cm H2O, Slope 0.20 s. The pressure-versus-time waveform (Fig. 1,
used, it is very important to individualize patients by evaluating the VTE, Top Waveform) shows that at the beginning of inspiration, the ventila-
Pplat, SpO2 and graphic waveforms soon after initiating PC-CMV. Even tor increases the airway pressure from the PEEP level of 6 cm H2O up to
though the tidal volume is not set directly, it is important to consider the set PIP of 24 cm H2O; the time to reach this PIP is set with the slope
the milliliters per kilogram (ml/kg) of tidal volume in relation to the and in this case, it is set at 0.20 s. Inspiration continues until the set in-
predicted body weight (PBW). Current recommendations are to keep spiratory time of 0.90 s has been reached. At that time, inspiration ends
tidal volume no N 6–8 ml/kg PBW, unless the patient has ARDS, in and the patient is allowed to exhale back to the PEEP level of 6 cm H2O.
which case the recommended tidal volume should be 4–6 ml/kg PBW.
Arterial blood gasses (ABGs) should be drawn and evaluated. Ventilator 8.2. Flow versus time waveform
changes to achieve a target PaCO2 are described below.
Mode: PC-CMV On a typical flow-versus-time graphic display, inspiratory flow is de-
PI: 5–10 cm H2O marcated above the horizontal baseline and expiratory flow is noted
TI: 0.7–1.0 s below that baseline. When looking at the flow-versus-time waveform
f: 10–20 BPM (Fig. 1, Middle Waveform) the flowrate increases immediately at the
FIO2: 0.5 beginning of inspiration and then gradually decreases throughout inspi-
PEEP: 5–10 cm H2O ration. Generally, the flow-versus-time waveform will be decelerating

Fig. 4. Inspiratory Pause. Fig. 4 shows that if the inspiratory time is too long, the alveolar pressure will reach the set airway pressure, resulting in an inspiratory pause (as indicated by the
red arrow). (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
174 L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182

during PC-CMV. At the end of inspiration, the inspiratory valve closes if the expiratory time is too short and there is not enough time for the
and the expiratory valve opens, allowing the patient to passively exhale. expiratory flowrate to return to baseline before the next breath begins,
If the expiratory time is long enough, the patient will be able to exhale to AutoPEEP is present (Fig. 5, Middle Waveform).
baseline before the next breath begins, and there will be no AutoPEEP. When ventilating a patient in PC-CMV, the presence of AutoPEEP
will reduce the actual Delta PInsp by the amount of the AutoPEEP. For ex-
8.2.1. Inspiration ample, if the PIP is set at 24 cm H2O, and the PEEP at 6 cm H2O, and
When using PC-CMV, the peak flowrate is dependent upon the Total AutoPEEP is 0 cm H2O, the Delta PInsp will equal 24 cm H2O – 6 cm
PEEP, set PIP and Slope, as well as the patient's airway resistance, pul- H2O = 18 cm H2O. However, if the patient has a Total PEEP 7.8 cm
monary compliance, and effort. The difference between the PIP and H2O, but the set PEEP is 6 cm H2O, AutoPEEP is present and can be cal-
the alveolar pressure is frequently referred to as the Delta PInsp (PIP – al- culated as 7.8 cm H2O (TotalPEEP) – 6 cm H2O (set PEEP) = 1.8 cm
veolar pressure). During inspiration, as the alveolar pressure increases, H2O (AutoPEEP). This means that the alveoli are actually starting at
the Delta PInsp decreases (Fig. 2), resulting in a decreasing inspiratory 7.8 cm H2O (Total PEEP) rather than 6 cm H2O (PEEP), which results
flowrate. If the inspiratory time is long enough for the alveolar pressure in a reduction in the Delta PInsp by 1.8 cm H2O, resulting in an overall de-
to equilibrate with the set pressure, the inspiratory flow waveform will crease in delivered tidal volume (Fig. 6).
return to baseline (Fig. 1, Middle Waveform). However, if the inspirato- During PC-CMV, if AutoPEEP exists and is subsequently reduced
ry time is not long enough for the alveolar pressure to reach the set pres- (e.g. a reduction in airway resistance after delivery of an inhaled
sure, the inspiratory flow waveform will not return to baseline. This bronchodilator), the Delta PInsp will increase. This usually results in
generally results in a lower alveolar pressure and a reduced tidal vol- an increase in delivered tidal volume. Options to reduce the
ume (Fig. 3, Middle Waveform). If the inspiratory time continues after AutoPEEP in PC-CMV include decreasing airway resistance and/or in-
the inspiratory flow has returned to the zero-flow baseline, an inspira- creasing expiratory time. Expiratory time can be increased by
tory pause will occur (Fig. 4, Middle Waveform). decreasing respiratory rate and/or decreasing inspiratory time
(Fig. 7). However, it is important to make sure that a decrease in re-
8.2.2. Exhalation spiratory rate does not result in a decreased minute ventilation, es-
If the expiratory time is long enough for the expiratory flowrate to pecially in a spontaneously breathing patient. Similarly, tidal
return to the zero-flow baseline before the beginning of the next inspi- volume must be monitored carefully as a decrease in inspiratory
ration, there will be no AutoPEEP (Fig. 1, Middle Waveform). However, time may result in a decreased tidal volume.

Fig. 5. Identifying AutoPEEP. Fig. 5 demonstrates that if the expiratory time is too short, AutoPEEP is likely to result. The red arrow indicates that the next breath begins before expiratory
flow returns to baseline, resulting in AutoPEEP. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182 175

9. Making changes: an algorithmic approach 9.1.2. Increasing tidal volume


When a decision is made to increase the tidal volume, there are
9.1. Treatment of hypercapnia many options to consider. As illustrated in Fig. 9, increasing the PIP
should not be considered the default option. As discussed earlier, if the
9.1.1. Initial decision patient has low compliance, PC-CMV will result in a decreased tidal vol-
When a patient has an elevated PaCO2 resulting in a respiratory aci- ume at a given pressure. Consideration should be given to try to increase
dosis, and the decision is made to reduce the PaCO2, one must either de- the compliance by either increasing the PEEP level if it is too low (poten-
liver a larger tidal volume or increase the respiratory rate. In cases tially causing atelectasis), or by decreasing the PEEP level if it is too high
where ventilator induced lung injury is a concern, clinicians may choose (potentially resulting in overdistension), as both of these issues can re-
to not increase the tidal volume. sult in a low compliance.
When evaluating acid-base status, the first decision that has to be As previously described, AutoPEEP will reduce the effective Delta
made is whether or not the PaCO2 is high enough and/or the pH is low PInsp. Evaluating the patient for AutoPEEP should be part of the ongoing
enough to necessitate a reduction in PaCO2. If the PaCO2 is not N 50– patient assessment. If the patient has AutoPEEP, methods to decrease
70 Torr and the pH is not b7.25, the decision may be made to maintain the AutoPEEP should be considered. Such considerations include de-
current therapy. However, if there is a need to reduce PaCO2, the next creasing the airway resistance, increasing expiratory time by decreasing
decision is whether or not to increase minute ventilation by changing inspiratory time, prolonging the expiratory time by changing the I:E,
ventilator settings or to utilize other, non-ventilator strategies to de- and/or decreasing the respiratory rate.
crease the PaCO2 (Fig. 8). If the decision is made to change the ventila- The inspiratory flow waveform should be a major part of both rou-
tory setting to increase the minute ventilation, the Pplat and tidal tine and continual patient assessments. Throughout inspiration, as the
volume must first be evaluated. If the Pplat is b25–30 cm H2O (or less alveolar pressure increases, the inspiratory flow will return closer to
than the desired Pplat), or if the tidal volume is b 6–8 ml/kg PBW, and baseline. If the inspiratory flow does not return to baseline, an increase
if the desired outcome is an increase in tidal volume, then options to in- in inspiratory time will generally result in an increased tidal volume and
crease tidal volume should be considered (Fig. 9). If the decision is made should be considered as long as increasing inspiratory time does not re-
to not increase the tidal volume, then options to increase respiratory sult in shortening expiratory time, causing AutoPEEP, or result in pa-
rate should be considered (Fig. 10). If the decision is made to not in- tient-ventilator asynchrony. When the inspiratory flow waveform
crease tidal volume or respiratory rate, then non-ventilatory strategies does not return to baseline, the Pplat will be less than the set PIP.
should be considered (Fig. 11). When adjusting the inspiratory time, it is important to re-assess the

Fig. 6. Measurement of AutoPEEP. Fig. 6 demonstrates how to measure AutoPEEP. The red arrows indicate the end of the expiratory pause and the total PEEP displayed while the screen is
frozen. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
176 L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182

Fig. 7. Expiratory time. Fig. 7 illustrates the effect on expiratory time of changes in inspiratory time and total time.

Pplat and evaluate the patient-ventilator asynchrony that could be gradually to achieve the desired tidal volume, ensuring that the Pplat is
caused by the inspiratory time being too short or too long. b25–30 cm H2O.
The next step in a complete assessment is to evaluate the Pplat. If the If the Total PEEP is too high, it may lead to overdistension of alveoli.
Pplat is b 25–30 cm H2O, or less than the desired Pplat, and the tidal vol- This will generally result in a decrease in compliance and potentially an
ume is less than the desired tidal volume, PIP should be increased increase in alveolar dead space due to stretching of the alveoli and

Fig. 8. Initial decision. Fig. 8 demonstrates the initial decision necessary to determine how to reduce the PaCO2.
L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182 177

compression of the pulmonary capillaries. This causes reduced perfu- PEEP level can be identified as the point at which the highest Cdyn oc-
sion to the over-distended alveoli and an increase in the ventilation/ curred. The set PEEP level should be set 2–3 cm H2O above this point
perfusion ratio, which may increase the dead space and result in an in- [6,10].
creased PaCO2. A decremental PEEP trial involves decreasing the set If the desired increase in minute ventilation is achieved, ABG's
PEEP 1 or 2 cm H2O every one to two minutes while monitoring the dy- should be repeated after 30 min and the patient continually re-evaluat-
namic compliance (Cdyn), tidal volume, and SpO2. If the Total PEEP was ed. If the desired increase in minute is not achieved, see the section en-
too high, as the set PEEP is decreased, the Cdyn will increase. The optimal titled ‘the Initial Decision’ (Fig. 8).

Fig. 9. Increase tidal volume. Fig. 9 demonstrates the options that are available during PC-CMV to increase the tidal volume.
178 L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182

9.1.3. Increasing respiratory rate Because total time equals inspiratory time plus expiratory time, the
The total time in one respiratory cycle is the amount of time from the total time can be decreased by shortening inspiratory time, shortening
beginning of one breath (inspiration) to the beginning of the next expiratory time, or shortening inspiratory and expiratory time. The
breath. When the decision is made to increase the respiratory rate, the guide as to whether the inspiratory time or the expiratory time should
total time will be decreased. be shortened is based upon the flow-versus-time waveform (Fig. 10).
If the inspiratory flow returns to baseline and an inspiratory pause is
Total Time ð secÞ ¼ 60 s= min=f ðBPMÞ present, the inspiratory time can be decreased without producing any
change in tidal volume. However, care must be taken to not reduce in-
spiratory time to the extent that inspiratory flow no longer returns to
Total Time ¼ Inspiratory time þ Expiratory Time baseline, as this may result in a decrease in delivered tidal volume.

Fig. 10. Increase respiratory rate. Fig. 10 demonstrates the options that are available during PC-CMV to increase the set respiratory rate.
L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182 179

If the expiratory flow returns to baseline and is long enough to cause evaluated. If the desired increase in minute ventilation is not achieved,
an expiratory pause (no AutoPEEP), the expiratory time can be reduced see the section entitled ‘the Initial Decision’ (Fig. 8).
by increasing the respiratory rate by 2 BPM ensuring to carefully moni-
tor for AutoPEEP. If both an inspiratory pause and an expiratory pause 9.1.4. Nonventilatory change strategies for reducing PaCO2
are present, inspiratory time can be decreased along with increasing re- An increase in airway resistance increases the time constant, in-
spiratory rate by 2 BPM, again making sure that tidal volume is not de- creases the amount of time it takes for the alveolar pressure to reach
creased and AutoPEEP does not occur. the set pressure, and increases the likelihood of AutoPEEP. Therefore,
If the ventilator is set up to maintain a constant I:E ratio, it is impor- if the patient has an increased airway resistance that can be reduced,
tant to note that increasing the set rate will result in a proportional de- doing so will result in an increase in delivered tidal volume and the min-
crease in inspiratory time and expiratory time. The opposite is also true, ute ventilation should increase. Options to decrease the airway resis-
that decreasing the set respiratory rate will lengthen inspiratory time tance include administration of a bronchodilator, removal of
and expiratory time, proportionally. secretions, and possibly replacing an endotracheal or tracheostomy
If the desired increase in minute ventilation is achieved, ABG's tube which is obstructed with dry sputum or secretions. However, the
should be obtained after 30 min and the patient continually re- use of intravenous beta agonists has been shown to increase the

Fig. 11. Nonventilatory strategies. Fig. 11 demonstrates the non-ventilatory strategies to consider when a patient has an increased PaCO2.
180 L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182

mortality in patients with ARDS [11]. The use of Heliox may also be con- temperature is likely to reduce both CO2 production and the
sidered, as long as the FIO2 is low enough to allow for an 80/20 or 70/30 PaCO2. Other methods of reducing the metabolic rate and reducing
mixture of Helium/Oxygen, and the ventilator is calibrated for this mix- CO 2 production include a nutritional analysis to check for over
ture. Fig. 11 outlines a strategic approach to decreasing PaCO2 using feeding.
nonventilatory strategies. Permissive hypercapnia, as previously discussed, refers to using a
If the patient's CO2 production is increased, consider methods of limited minute ventilation and allowing the PaCO2 to gradually increase.
reducing CO2 production. Improved patient-ventilator synchrony Generally, as long as the increase in PaCO2 is gradual, and the pH N 7.25,
may reduce CO2 production and may require altering the inspiratory the respiratory acidosis is well-tolerated. However, some sedation is
time, expiratory time, I:E, Delta PInsp, or changing modes of ventila- usually required [5,6,9].
tion. Sedation, anesthesia, and neuromuscular blockade may be nec- If the desired decrease in CO2 production is achieved, ABGs should be
essary in some situations. If the patient has a fever, reducing the obtained within 30 min and the patient continually re-evaluated. If the

Fig. 12. Treat hypocapnia. Fig. 12 demonstrates options to consider when a patient has hypocapnia.
L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182 181

desired decrease in CO2 production is not achieved, refer to the section Table 1
entitled, ‘Initial Decision’ (Fig. 8). Summary of options to increase minute ventilation.
Table 1 is a summary of the available options to increase the minute ventilation during PC-
CMV.
9.2. Treating hypocapnia
Options to increase minute ventilation in PCV
This table summarizes options available in PC-CMV that should be considered
Auto-triggering refers to an additional breath being delivered that
when an increase in minute ventilation is desired.
was not triggered by the patient's inspiratory effort. Auto-triggering
Increase tidal volume (Vt) Increase respiratory rate (RR)
may occur if the ventilator sensitivity is set too high (too sensitive).
Goal Vt: b6–8 ml/kg PBW TTot = 60/rate TTot = TI + TE
Generally, a pressure trigger of −1 cm H2O is sufficient to allow the pa-
tient to trigger a breath, yet not so sensitive as to result in auto-trigger-
• Increase Delta P (Keep PPlat b25–30 cm H2O) • Decrease TTot
ing. A flow trigger of 2 or 3 LPM is generally sufficient and not too
○ Decrease AutoPEEP ○ Decrease TI
sensitive. Auto-triggering may also occur if there is a leak in the system, ▪ Decrease airway resistance ○ Decrease TE
such as that of an endotracheal cuff leak or a leak in a chest tube ▪ Increase TE ○ Decrease TI and TE
(bronchopleural fistula). When condensation collects in the circuit, • Decrease TI
the tidal motion of the water during inspiration and expiration can cre- • Decrease Rate

ate enough of a change in pressure or flow to trigger a breath. Always


make sure that condensation is not allowed to collect in the circuit. An- ○ Increase Ti (if PPlat b PIP)
other cause of auto-triggering is referred to as cardiac triggering. Pa- ○ Increase PIP
tients who have hyper-dynamic cardiac pulsations may experience ○ Decrease Set PEEP (If over-distended)
▪ Monitor Oxygenation
enough movement of the ventricle to trigger a breath. This is sometimes
seen in patients who are in a high cardiac output state of sepsis. Auto-
triggering may also occur from the inflation and deflation of an intra-
aortic balloon bump. If this occurs, it may be necessary to make the ven-
tilator slightly less sensitive to the patient's effort to eliminate the Auto- ventilator synchrony and reduces the work of breathing. Even though
triggering. Double-triggering refers to the patient continuing to inhale, multiple articles have been published on PC-CMV, there is little evi-
even though the inspiratory time has terminated; this results in two dence that PC-CMV improves outcomes when compared to VC-CMV.
breaths without an exhalation, and an increased tidal volume. Inspirato- However, this may be due to inconsistencies in ventilator management
ry time should be checked to make sure that it is not inappropriately too strategies during PC-CMV.
short. The algorithms and descriptions included in this article are intended
When evaluating acid-base status, if the PaCO2 is b30 Torr or the pH to provide a standardized approach to the management of PC-CMV.
is N 7.50, it is important to determine whether or not there are treatable Every patient is unique and needs to be evaluated individually; howev-
causes of an increased minute ventilation such as pain and anxiety. If er, these algorithms and descriptions are intended to provide the clini-
there are no treatable causes and the decision is made to decrease the cian with a systematic method of evaluating the patient's physiology,
minute ventilation, the ventilator should first be checked for auto-trig- clinical status, ventilating pressures, and ventilator graphics, resulting
gering and for double-triggering. in a logical progression through which to recommend appropriate
The next step in reducing the minute ventilation is to evaluate the changes in ventilator settings.
plateau pressure and tidal volume. If the plateau pressure is N 25– As summarized in Table 1, when a clinician wants to increase the
30 cm H2O or greater than the desired plateau pressure, or if the tidal minute ventilation, either the tidal volume can be increased or the re-
volume is N6–8 ml/kg PBW or greater than the desired tidal volume, spiratory rate can be increased. However, there are multiple options
the Delta PInsp can be reduced in steps of 1 or 2 cm H2O. available that will result in an increased tidal volume and several op-
If the plateau pressure is not N25–30 cm H2O and is not greater than tions available that will result in an increased respiratory rate. Selecting
the desired plateau pressure and the tidal volume is not N6–8 ml/kg which option is appropriate for any given patient requires the clinician
PBW and is not greater than the desired tidal volume, the respiratory to progress through a systematic analysis of each option, after a thor-
rate can be decreased. If the inspiratory flow returns to baseline, then ough evaluation of the patient.
the respiratory rate can be reduced by 2 breaths per minute, without
changing the inspiratory time. This will increase the expiratory time
and result in a reduced minute ventilation. If an inspiratory pause is 11. Summary
present, inspiratory time can be reduced, eliminating the inspiratory
pause, and the respiratory rate can be reduced. If the inspiratory Pressure-controlled ventilation is a method of ventilating patients
flowrate does not return to baseline, increase inspiratory time by 0.1– that may be beneficial for some patients. However, successful utilization
0.2 s and reduce the respiratory rate by 2 breaths per minute. Always as- of the mode requires a thorough understanding of PC-CMV, physiology,
sess the patient to ensure that the patient does not become asynchro- pathophysiology, graphic analysis, and the mechanical aspects of each
nous with the ventilator when changing inspiratory time. Usually, an specific ventilator. If a standardized and systematic approach is used
inspiratory time of 0.6–1.2 s is appropriate. Rarely is an inspiratory to manage patients being ventilated in PC-CMV, it is possible that future
time N 1.2 s well tolerated by patients. The suggested method of treating studies will be performed that use more comparable treatment algo-
hypocapnia while in PC-CMV is illustrated in Fig. 12. rithms between studies. The goals of identifying a consistent approach
If the desired decrease in minute ventilation is achieved, the patient to the management of PC-CMV are to glean comparable data in an effort
should be continually monitored, including oxygenation. However, if to try to determine whether or not there is a significant difference in
the desired decrease in minute ventilation is not achieved, the PaCO2 outcomes when ventilating patients with PC-CMV versus VC-CMV,
and pH should be re-evaluated, as listed at the top of this algorithm. and to improve management of patients ventilated with PC-CMV.

10. Discussion
References
Pressure-targeted ventilation allows the clinician to control the air-
[1] Post, M.L. Pressure-controlled ventilation. RTMagazine.com 2012 (02). Retrieved
way pressure and allows the patient to influence the inspiratory from file://Users/Megan/Downloads/rtmagazine.com-Pressure-Controlled%
flowrate and tidal volume. In some cases, this improves patient- 20Ventilation.pdf.
182 L. Ashworth et al. / Journal of Critical Care 43 (2018) 169–182

[2] Kallet RH, Campbell AR, Alonso JA, et al. The effects of pressure control versus vol- [7] Marini JJ, Crooke PS. Determinants and limits of pressure-preset ventilation: a math-
ume control assisted ventilation on patient work of breathing in acute lung injury ematical model of pressure control. J Appl Physiol 1989;67(3):1081–92.
and acute respiratory distress syndrome. Respir Care 2000;45(9):1085–96. [8] Amato M, Meade MO, Slutsky AS, et al. Driving pressure and survival in the acute re-
[3] Rittayamai N, Katsios CM, Beloncle F, et al. Pressure-controlled vs volume-controlled spiratory distress syndrome. N Engl J Med 2015;372(8):747–755.1.
ventilation in acute respiratory failure. Chest 2015;148(2):340–55. [9] Peltekova V, Engelberts D, Otulakowski G, et al. Hypercapnic acidosis in ventilator-
[4] Chacko B, Peter JV, Tharyan P, et al. Pressure-controlled versus volume controlled- induced lung injury. Intensive Care Med 2010;36(5):869–78.
ventilation for acute lung injury (ALI) or acute respiratory distress syndrome [10] Kacmarek RM, Villar J, Sulemanji D, et al. Open lung approach for the acute respira-
(ARDS) (review). Cochrane Database Syst Rev 2015 Jan 14;1:CD008807. tory distress syndrome: a pilot, randomized controlled trial. Crit Care Med 2016;
[5] Tobin MJ. Principles and practice of mechanical ventilation. 3rd ed. McGraw Hill; 44(1):32–42.
2013. [11] Smith FG, Perkins GD, Gates S, et al. Effect of intravenous B-2 agonist treatment on
[6] Kacmarek RM, Stoller JK, Heuer AJ. Egan's fundamentals of respiratory care. 10th ed. clinical outcomes in acute respiratory distress syndrome (BALTI-2): a multicentre,
Elsevier; 2013. randomized controlled trial. Lancet 2012;379(9812):229–35.

Вам также может понравиться